logo inner

Senior Director, Regulatory Affairs Europe

CytokineticsZug, SwitzerlandOnsite

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility.
Cytokinetics is seeking a highly experienced Senior Director, Regulatory Affairs Europe to join the Regulatory Affairs team in Europe. The individual will provide leadership in developing and executing best in class regulatory strategies for assigned programs in the European region. The Senior Director will lead all regulatory activities related to the submission of Marketing Authorization Applications of assigned Cytokinetics products in Europe (including UK and Switzerland) as well as implementation of post-marketing requirements.

The Senior Director, Regulatory Affairs Europe will work closely with the Global Regulatory Lead and be a member of the Global Regulatory Team. The individual will work cross-functionally including with Clinical Research, Medical Affairs, Drug Safety, Quality, Market Access and, as established country operations to ensure all regional and local regulatory requirements are met.  The individual will ensure regional and local regulatory compliance over all relevant aspects of the business in the European region. The individual will work closely with the VP, Head of Regulatory Affairs Europe, to develop the regulatory processes related to the launch of Cytokinetics commercial products in the region.The Senior Director will also maintain awareness of the regulatory environment and communicate the impact of changes on business and product development programs. The Senior Director may deputize for the Head of Regulatory Affairs Europe as appropriate.

Responsibilities:


  • Develop a robust European strategy for specific products aligning with the Global regulatory strategy and cross functionally to identify the best strategy that will lead to European approval.
  • Contribute and independently execute the filing plans for Europe in line with corporate, regional and local business objectives.
  • Ensure high-quality regulatory submissions are made on time and meet Cytokinetics requirements.
  • Collaborate with the Regulatory Study Lead to review and provide strategic input/advice to EU CTR submissions and/or queries.
  • As part of the Global Regulatory Team (GRT), provide direction and expertise on regional and local regulatory mechanisms to optimize product development.
  • Provide strategic and operational contributions to EMA/national agencies interactions and their preparation.
  • Maintain an awareness of new and developing legislation, regulatory policy and technical guidance relating to Cytokinetics products and discuss their implications with business.
  • Assesses country and regional‐specific regulations/requirements, and develops proactive regulatory plans and strategies, aligned with business goals.
  • Oversees regulatory-related launch and post-marketing activities in the EU:
  • Provides regulatory input to market access strategy and HTA plans and submissions in the EU
  • Ensures local regulatory requirements are fulfilled in each country
  • Reviews all promotional/disease awareness and internal training materials to ensure they meet requirements of the applicable EU Directives and national regulations
  • Ensures all packaging and labeling requirements are met according to local requirements
  • Ensures all post-marketing requirements and maintenance activities are met
  • Work closely with the Quality department on relevant regulatory procedures applicable to the European region.

Qualifications


  • Seasoned professional with a minimum of 12 years of relevant experience with a solid expertise and knowledge of the applicable European regulatory regulations, directives and guidelines.
  • Bachelor of Science in a scientific discipline, Pharm D (/Pharmacist) or PhD preferred.
  • Proven track record of directly leading Marketing Authorization Applications through EMA centralized procedure and national agencies (including Switzerland and UK). Experience in international markets is advantageous.
  • Strong experience leading or participating in regulatory agency interactions.
  • Solid foundation in science obtained through academics and business experience.
  • Must be a strong team player, a fully engaged, hands-on professional capable of working collaboratively and independently, with excellent verbal and written communication skills.
  • Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects.
  • Strong interpersonal capabilities and ability to build and maintain networks.
  • Possesses sense of urgency; identifies challenges and problems and takes the initiative to identify solutions.

Our employees come from different backgrounds, and we celebrate those differences. We are looking for the best candidates for our open roles, but do not expect applicants to meet every qualification in order to be considered. If you are excited about what you could accomplish at Cytokinetics and believe you can add value to our team, we would love to hear from you.

Please review our General Data Protection Regulation (GDPR) policy PRIOR to applying.  


Our passion is anchored in robust scientific thinking, grounded in integrity and critical thinking. We keep the patient front and center in all we do – all actions and decisions are in service of the patient and their caregivers. We champion integrity, ethics, doing the right thing, and being our best selves.

Fraud Warning: How to Identify Impersonated Cytokinetics Job Postings and Offers


Recently, there have been fraudulent employment offers being sent to candidates on behalf of Cytokinetics. Please be advised that all legitimate offers from Cytokinetics will come directly from our official email domain (Cytokinetics.com) and will only be made after completing a formal interview process.Here are some ways to check for authenticity:

  • We do not conduct job interviews through non-standard text messaging applications
  • We will never request personal information such as banking details until after an official offer has been accepted and verified
  • We will never request that you purchase equipment or other items when interviewing or hiring
  • If you are unsure about the authenticity of an offer, or if you receive any suspicious communication, please contact us directly at talentacquisition@cytokinetics.com

Please visit our website at: www.cytokinetics.com


Cytokinetics is an Equal Opportunity Employer



Life at Cytokinetics

We are a leading biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. A number of commonly used drugs and a growing body of research validate the role that the cytoskeleton plays in a wide array of human diseases. Our focus on the cytoskeleton enables us to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, cardiovascular disease, fungal diseases and other diseases. We have developed a cell biology driven approach and proprietary technologies to evaluate the function of many interacting proteins in the complex environment of the intact human cell. We believe that our approach enhances the speed, efficiency and yield of our drug discovery and development process by accurately and rapidly identifying drug candidates with attractive properties. Our approach has yielded two drug candidates for the treatment of cancer, a drug candidate for the treatment of acute congestive heart failure and more than ten other research programs. Our most advanced drug candidate, SB-715992, is the subject of a broad Phase II clinical trials program designed to evaluate its effectiveness in many different types of cancer. An investigational new drug application, or IND, was filed with the U.S. Food and Drug Administration, or FDA, in 2003 for our second cancer drug candidate, SB-743921, which we expect will enter Phase I clinical development in early 2004. SB-715992 and SB-743921 are being developed through our strategic alliance with GlaxoSmithKline. In addition, we expect to initiate Phase I clinical development for a drug candidate, CK-1213296, for the treatment of acute congestive heart failure in the second half of 2004.
Thrive Here & What We Value1. Passionate about robust scientific thinking grounded in integrity and critical thinking2. Celebrates differences among employees3. Patient-centric approach to all actions and decisions4. Values integrity, ethics, doing the right thing, and being our best selves5. Emphasis on patient-centered care6. Focus on innovation and continuous improvement7. Dedicated to keeping the patient front and center in all actions and decisions8. Values-driven and sustainable approach to drug discovery and development9. Rigorous scientific thinking and critical thinking10. Emphasis on collaboration across different departments and teams
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024